Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa

Clinical trial NCT06591793 · RECRUITING

Trial details

NCT number: NCT06591793
Sponsor: AAVantgarde Bio Srl
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Usher Syndrome, Type 1B

Start date: 2024-07-02
Primary completion: 2025-07-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.